Fu-Zhi Ji
About
In The Last Decade
Fu-Zhi Ji
12 papers receiving 373 citations
Peers
Comparison fields: 5 of 51
- Pulmonary and Respiratory Medicine 195
- Molecular Biology 120
- Surgery 113
- Cancer Research 91
- Gastroenterology 58
Countries citing papers authored by Fu-Zhi Ji
This map shows the geographic impact of Fu-Zhi Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu-Zhi Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu-Zhi Ji more than expected).
Fields of papers citing papers by Fu-Zhi Ji
This network shows the impact of papers produced by Fu-Zhi Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu-Zhi Ji. The network helps show where Fu-Zhi Ji may publish in the future.
Co-authorship network of co-authors of Fu-Zhi Ji
This figure shows the co-authorship network connecting the top 25 collaborators of Fu-Zhi Ji. A scholar is included among the top collaborators of Fu-Zhi Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fu-Zhi Ji. Fu-Zhi Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 5 | |
| 3 | 73 | |
| 4 | 29 | |
| 5 | 24 | |
| 6 | 6 | |
| 7 | Bispecific tumor-penetrating protein anti-EGFR-iRGD efficiently enhances the infiltration of lymphocytes in gastric cancer. | 9 |
| 8 | 20 | |
| 9 | 33 | |
| 10 | 57 | |
| 11 | [A randomized controlled trial of intensity-modulated radiation therapy plus docetaxel and cisplatin versus simple intensity-modulated radiation therapy in II-III stage esophageal carcinoma]. | 3 |
| 12 | 116 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.